Green Alpha Advisors LLC Has $154,000 Holdings in Quantum-Si incorporated (NASDAQ:QSI)

Green Alpha Advisors LLC grew its position in Quantum-Si incorporated (NASDAQ:QSI) by 35.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 175,055 shares of the company’s stock after purchasing an additional 45,796 shares during the quarter. Green Alpha Advisors LLC owned about 0.12% of Quantum-Si worth $154,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Public Employees Retirement System of Ohio bought a new stake in Quantum-Si in the 1st quarter valued at about $27,000. Bleakley Financial Group LLC bought a new stake in shares of Quantum-Si in the first quarter valued at approximately $28,000. XTX Topco Ltd acquired a new stake in Quantum-Si during the second quarter worth approximately $25,000. Virtu Financial LLC acquired a new stake in Quantum-Si during the first quarter worth approximately $98,000. Finally, Price T Rowe Associates Inc. MD raised its holdings in Quantum-Si by 11.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 59,727 shares of the company’s stock valued at $118,000 after acquiring an additional 5,945 shares in the last quarter. Institutional investors own 39.90% of the company’s stock.

Insider Activity at Quantum-Si

In other Quantum-Si news, CFO Jeffry R. Keyes bought 50,000 shares of the business’s stock in a transaction on Friday, August 9th. The stock was purchased at an average cost of $0.87 per share, for a total transaction of $43,500.00. Following the completion of the purchase, the chief financial officer now directly owns 446,820 shares of the company’s stock, valued at approximately $388,733.40. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. In other Quantum-Si news, CFO Jeffry R. Keyes bought 50,000 shares of the stock in a transaction on Friday, August 9th. The stock was purchased at an average price of $0.87 per share, with a total value of $43,500.00. Following the completion of the purchase, the chief financial officer now owns 446,820 shares in the company, valued at $388,733.40. The trade was a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Charles R. Kummeth bought 31,100 shares of the company’s stock in a transaction dated Monday, August 12th. The stock was bought at an average cost of $0.89 per share, with a total value of $27,679.00. Following the acquisition, the director now directly owns 355,000 shares of the company’s stock, valued at approximately $315,950. The trade was a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought 245,000 shares of company stock valued at $213,522 over the last three months. 30.04% of the stock is owned by insiders.

Quantum-Si Stock Performance

NASDAQ:QSI opened at $0.83 on Tuesday. Quantum-Si incorporated has a fifty-two week low of $0.73 and a fifty-two week high of $2.43. The company has a market cap of $117.92 million, a price-to-earnings ratio of -1.32 and a beta of 2.86. The stock has a fifty day moving average price of $0.93 and a 200-day moving average price of $1.30.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.05. Quantum-Si had a negative net margin of 5,249.65% and a negative return on equity of 33.02%. The firm had revenue of $0.62 million for the quarter, compared to the consensus estimate of $0.66 million. Research analysts predict that Quantum-Si incorporated will post -0.71 EPS for the current fiscal year.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.